Analyst Group inleder idag den 21:e februari 2024 analysbevakning på Cedergrenska AB (”Cedergrenska”...
Sales SEK 53m and EBIT SEK -5m (vs. ABGSCe 49m & -4m) Changed reporting period, now follows calendar...
Orders +43%, sales -3% vs. ABGSCe EBIT adj. EUR 3.8m, for a margin of 8.
Redeye comments on Binero IT’s H2-24 results. Sales were SEK212m in the second half of the year, rep...
Redeye saw a sales development that was just below our expectations.
Redeye shares its initial comments on Modelon’s Q4 2024 results, where ARR slightly exceeded expecta...
Redeye notes that Sivers’ Q4 2024 report was strong, with record net sales of SEK76.
We upgrade our Q4 EBIT forecast slightly, due to 18% y/y growth in cargo vessel calls.
Redeyes’ long-term view of Dignitana continues to be positive.
Redeye updates its estimates after reviewing Fable Media Group’s Q4 report, which was in line with o...
Redeye returns with an updated view on Lifecare following its year-end report, which warranted some ...
Redeye updates its estimates and valuation following Navigo releasing its Q4 2024 report.
Ferronordic reported a mixed set of Q4 2024 numbers, with sales clearly beating our expectation, lar...
Redeye strengthens its positive view of Teneo AI following a Q4 report with substantially accelerati...
New partnership with major European defence company Expected to materialise in orders relatively nea...
Germany weaker than expected, US stronger We make more cuts in Germany High leverage is the bottlene...
We expect positive organic growth from H2'25 EBIT estimates cut 2%, mainly on FX Share is trading at...
First Venture publicerade den 20 februari 2025 Bolagets delårsrapport för det fjärde kvartalet av 20...
Redeye leaves a short comment on yesterday's announcement that all patients in the ProTrans V study ...
Redeye provides a research update following the Q4 report published by Cinclus earlier today.